Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketorolac + midazolam is a combination used for sedation and pain management, particularly in surgical settings. This combination leverages the complementary effects of both medications: **Ketorolac** is a non-steroidal anti-inflammatory drug (NSAID) with potent analgesic, anti-inflammatory, and antipyretic properties. It works by blocking substances in the body that cause pain and inflammation. **Midazolam** is a short-acting benzodiazepine with anxiolytic, muscle relaxant, anticonvulsant, sedative, hypnotic, and amnesic properties. When used together, this combination provides effective sedation and pain control while allowing patients to remain conscious during procedures. The combination has been studied in oral surgery and gynecologic procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ketorolac + midazolam.